The only known function of Cu,Zn-superoxide dismutase (SOD1) is to catalyze the dismutation of superoxide anion into hydrogen peroxide. Our objective was to determine if SOD1 catalyzes murine liver protein nitration induced by acetaminophen (APAP) and lipopolysaccharide (LPS). Liver and plasma samples were collected from young adult SOD1 knockout mice (SOD1 −/− ) and wild-type (WT) mice at 5 or 6 h after an ip injection of saline, APAP, or LPS. Hepatic nitrotyrosine formation was induced by APAP and LPS only in the WT mice. The diminished hepatic protein nitration in the SOD1 −/− mice was not directly related to plasma nitrite and nitrate concentrations. Similar genotype differences were seen in liver homogenates treated with a bolus of peroxynitrite. Adding only the holo-, and not the apo-, SOD1 enzyme into the liver homogenates enhanced the reaction in an activity-dependent fashion and nearly eliminated the genotype difference at the high doses. Mass spectrometry showed four more nitrotyrosine residues in bovine serum albumin and 10 more nitrated protein candidates in the SOD1 −/− liver homogenates by peroxynitrite with added SOD1. In conclusion, the diminished hepatic protein nitration mediated by APAP or LPS in the SOD1 −/− mice is due to the lack of SOD1 activity per se. © 2008 Elsevier Inc. All rights reserved.
Peroxynitrite is formed by a rapid diffusion-limited, radical-radical coupling reaction between nitric oxide (NO) and superoxide anion [11, 12] . Peroxynitrite can directly react with target molecules such as glutathione via one-or two-electron oxidation [13] or yield radical NO 2 via homolysis that nitrates tyrosine residuals of proteins into nitrotyrosine [14] . This particular chemical modification of tyrosine residues is called protein nitration [12, 15] . With the potential to inactivate or alter the functions of the modified proteins [16] [17] [18] , protein nitration has been suggested as an early biomarker for the degeneration of motor neurons in amyotrophic lateral sclerosis (ALS) and of the brain in Alzheimer disease [19] [20] [21] [22] . It has also been proposed as a mediator of APAP-induced hepatotoxicity [23] [24] [25] [26] [27] [28] . Coincidentally, alterations in SOD1 expression are related to Down syndrome [29] , ALS [30] , and body resistance to acetaminophen toxicity [7, 31] .
Despite these pathological implications, the earlier observed in vitro catalytic role of SOD1 in nitrotyrosine formation [9, 10] has been largely dismissed or neglected. There has been no experiment to test a cause-effect relationship between SOD1 and protein nitration in vivo. The extremely short biological half-life of peroxynitrite [32] and the lack of specific in vivo models have made such a test very difficult, if not impossible. The development of SOD1 knockout (SOD1 −/− [1] and the demonstration that several drugs such as APAP induce protein nitration in tissues [24, 25, 33, 34] provide us with an unprecedented opportunity to study the in vivo role of SOD1 in nitrotyrosine formation. Furthermore, the application of mass spectrometry allows the identification of specific nitrated protein candidates in tissue homogenates and particular residues in selected proteins. Therefore, we used SOD1 −/− and wild-type (WT) mice and conducted a series of in vivo and in vitro experiments to determine: (1) if SOD1 knockout diminishes hepatic protein nitration induced by various types and doses of stimuli, (2) if such impact of SOD1 is independent of NO production, (3) if the changes in protein nitration due to SOD1 knockout could be reversed by the holo-or apo-SOD1 enzyme, and (4) if SOD1 catalyzes nitrotyrosine formation selectively in target proteins of liver homogenates and/or certain tyrosine residues in bovine serum albumin (BSA).
Materials and methods

Chemicals and antibodies
All chemicals, including bovine SOD1 protein, were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless otherwise indicated. Peroxynitrite was purchased from Calbiochem (San Diego, CA, USA). Mouse anti-nitrotyrosine antibody was from Upstate Biotechnology (Lake Placid, NY, USA), and anti-mouse IgG was from Pierce (Rockford, IL, USA). Human holo-and apo-SOD1 protein (Cu,Zndepleted) [35] was kindly provided by Dr. John Hart, University of Texas Health Science Center at San Antonio.
Animals and treatments
Our experiments were approved by the Institutional Animal Care and Use Committee at Cornell University and conducted in accordance with the NIH guidelines for animal care. The SOD1 −/− and WT mice were generated from 129SVJ × C57BL/6 mice [1] . All used mice were 8-10 weeks of age and were fed a diet containing adequate levels of all required nutrients. To determine if SOD1 knockout exerted a general impact on hepatic protein nitration, we injected (intraperitoneally) mice with two different stimuli: APAP and lipopolysaccharide (LPS). The former is a widely used analgesic and antipyretic drug that raises plasma nitrate/nitrite concentrations and produces nitrotyrosine adducts in centrilobular areas of liver [24, 25, 27] . The latter induces the release of NO and superoxide in targeted tissues, leading to the formation of peroxynitrite and protein nitration [33, 36] . Based on preliminary experiments, we selected injections of APAP at 300 and 600 mg/kg body wt and of LPS at 5 mg/kg body wt. The two compounds were prepared in phosphate-buffered saline (PBS). The WT and SOD1 −/− mice (n = 4-8 for each treatment by genotype) were euthanized for blood and liver sample collection at 5 and 6 h postinjection with APAP and LPS, respectively. For both stimuli, the same numbers of WT, SOD1
, and respective control mice were injected with PBS and euthanized.
Hepatic protein nitration, antibody verification, and plasma NO production Both immunohistochemistry and Western blot were used to characterize the impact of SOD1 knockout on liver nitrotyrosine formation. The Histomouse-MAX kit (Zymed, South San Francisco, CA, USA) was used for immunostaining of liver sections, and a 12% gel was run to separate liver homogenates (50 μg protein/lane) for Western analysis. Specificity of the antibody against nitrotyrosine was verified by using 10 mM sodium dithionite to reduce nitrotyrosine on the blotting membrane and incubating the antibody with 20 μM 3-nitrotryosine overnight for a prior block [37] . Protein concentration was measured by the Lowry method [38] . As an indicator of NO production, plasma nitrate and nitrite concentrations were measured [39, 40] to test if the impact of SOD1 knockout on hepatic protein nitration was related to NO formation.
In vitro analysis of SOD1-catalyzed protein nitration
A series of experiments with mouse liver homogenates or BSA was conducted to determine: (1) if the observed genotype difference in the induced hepatic protein nitration was actually due to the SOD1 activity and not other changes associated with the gene ablation, (2) if the hepatic protein nitration in the SOD1 −/− mice was limited by formation of peroxynitrite, and (3) if the catalysis of SOD1 enzyme in protein nitration was dependent on its activity (the presence of metal Cu). Liver samples of WT and SOD1 −/− mice treated with PBS or APAP were homogenized in 50 mM potassium phosphate buffer, pH 7.8, 0.1% Triton X-100, 1.34 mM diethylenetriaminepentaacetic acid. The homogenates were centrifuged at 14,000 g for 20 min at 4°C, and the resulting supernatants were adjusted to the same protein concentration (7.5 mg/ml). The same buffer was also used to prepare the BSA solution (7.5 mg/ml). For each reaction, 16.4 nmol of peroxynitrite [41] was mixed with 150 μg of liver homogenate protein (20 μl) or 300 μg of BSA (40 μl) in the presence or absence of various amounts of SOD1 enzyme. The added SOD activities ranged from one to four times the WT activity, and the mixture volumes were controlled to ensure identical peroxynitrite concentrations between the different treatments. The mixture was incubated for 5 min at 37°C and then put on ice. The SOD activities of bovine SOD1 and human holo-SOD1 were 3.4 × 10 4 and 9.6 × 10 4 units/mg protein, respectively. Little SOD activity was detected with human apo-SOD1 protein. Total SOD activity was measured using a water-soluble formazan dye kit (Dojindo Molecular Technologies, Gaithersburg, MD, USA), following the manufacturer's instructions. After the peroxynitrite treatment, 50 μg of protein from the liver homogenate mixture or 5 μg of protein from the BSA mixture was used for analysis of nitrotyrosine formation by Western blot (as described above) and mass spectrometry (see below).
Nitrotyrosine characterization by mass spectrometry
After the peroxynitrite-mediated nitrotyrosine formation was verified by Western blot, a portion of the BSA solution (containing 76 pmol of protein) was reduced, alkylated, and digested with trypsin as described previously [42] . The peroxynitrite-treated WT and SOD1
−/− liver homogenates (200 µg of protein) were preincubated with 2 μg of the anti-nitrotyrosine antibody for 1 h before 20 μl of protein G agarose beads was added for overnight incubation at 4°C with constant agitation. The mixture was then centrifuged at 3000 g for 1 min and the precipitate was washed five times with 1 ml of the homogenization buffer. After being boiled for 5 min in the sample buffer, the resulting supernatants were loaded onto two lanes (10% vs 90% of sample) for SDS-PAGE (12% gel). The lane with the 10% sample was used for Western blot analysis, whereas the other lane was stained with deep purple (Amersham, Piscataway, NJ, USA). Bands corresponding to positive Western blot bands were excised, digested in situ, and extracted [42] . The in-gel-extracted tryptic peptides were reconstituted in 15 μl of 0.5% formic acid containing 2% acetonitrile, and 6.4 μl of this solution was used for nanoLC-MS/MS analysis as described previously [43] . The solution-based BSA digests were treated in a similar manner. The MS/MS data generated from nanoLC/ESI-based information-dependent acquisition analysis were submitted to Mascot 1.9 for database searching using an in-house licensed Mascot local server and the search was performed to query the NCBInr database (taxonomy: mammals) with one missed cleavage site by trypsin allowed. The peptide tolerance was set to 2 Da and MS/MS tolerance was set to 0.8 Da. Only significant scores for the peptides defined by Mascot probability analysis (www.matrixscience.com/help/ scoring_help.html#PBM) greater than bidentityQ were considered for the peptide identification.
Computer modeling
A three-dimensional model for the sequence of BSA was generated from comparative protein modeling using the program Modeller [44, 45] . The input data for Modeller were: (a) the template structure, corresponding to the experimentally determined structure of human serum albumin, monomer A, obtained from the Protein Data Bank code 1AO6, and (b) a sequence alignment of BSA and human serum albumin, obtained by using the program BLAST [46, 47] .
Statistical analysis
Numerical data were analyzed using the general linear model procedure in SAS (release 6.11, SAS Institute, Cary, NC, USA). Statistical significance was defined as P b 0.05.
Results
Knockout of SOD1 diminishes both APAP-and LPS-induced liver protein nitration
Little hepatic SOD activity was detected in the SOD1 −/− mice, and the treatment of 600 mg APAP/kg resulted in a decrease (P b 0.05) in the enzyme activity in the WT mice (Table 1) . Western blot analysis showed strong bands of hepatic nitrotyrosine formation in the WT mice treated with 300 mg of APAP/kg (Fig. 1A) , 600 mg of APAP/kg (Fig. 1B) , or LPS (Fig. 1C) . The same treatments produced little hepatic protein nitration in the SOD1 −/− mice. Immunostaining was performed to confirm this genotype difference further in mice treated with 300 mg APAP/kg (Fig. 1D) . Whereas the PBS-treated WT and SOD1 −/− mice showed little background, there was intense staining (brown color) scattered in the hepatic lobules of the WT mice treated with APAP. The positively stained fine granules appeared in the cytoplasm within the degenerated hepatocytes in the central lobular regions. The intravascular erythrocytes, fibroblast-like cells in the triads, and endothelial cells were also stained positive. In contrast, very little hepatocellular nitrotyrosine staining was detected in the APAP-treated SOD1 −/− mice. 
Plasma NO concentration varies with treatments and genotypes
Compared with the PBS-injected controls, both APAP doses of 300 ( Fig. 2A) and 600 mg/kg (Fig. 2B) led to an increase (P b 0.05) in plasma NO concentrations in the WT mice. The increases in the SOD1 −/− mice were significant (P b 0.05) only at the dose of 600 mg/kg. Plasma NO concentrations in the SOD1 −/− mice were 79 and 49% lower (P b 0.05) than those in the WT mice treated with 300 and 600 mg APAP/kg, respectively. The LPS treatment caused similar increases (P b 0.05) in plasma NO concentrations in the two genotypes (Fig. 2C) .
Bovine SOD1 rescues the peroxynitrite-mediated protein nitration in liver homogenates of SOD1 −/− mice Compared with the respective controls, the peroxynitrite treatment produced much stronger formation of nitrotyrosine in the liver homogenates of WT mice than in those of the SOD1 −/− mice (Figs. 3 and 4A). Adding the SOD1 enzyme into the liver homogenates greatly enhanced the reactions in both genotypes, and the enhancements were SOD activity dependent (Fig. 3) . Accordingly, the dose of four times the WT activity was selected for further analyses. There was little total SOD activity in the liver homogenates of the SOD1 −/− mice, and the activity was decreased by 27% (P b 0.05) in the WT mice after the peroxynitrite treatment (Fig. 4B, top) . When bovine SOD1 was added to the liver homogenates, total SOD activities in both genotypes were increased and were not significantly decreased by the peroxynitrite treatment (Fig. 4B, bottom) . Likewise, the peroxynitritemediated nitration of BSA was greatly enhanced by the addition of bovine SOD1 enzyme (Fig. 4C) . The added bovine SOD1 activity in the BSA reaction mixture was decreased (P b 0.05) after the peroxynitrite treatment (Fig. 4D ).
Apo-SOD1 is unable to catalyze the peroxynitrite-mediated nitrotyrosine formation
Adding the apo-human SOD1 protein to the liver homogenates of WT and SOD1 −/− mice or the BSA mixture failed to enhance the peroxynitrite-mediated nitrotyrosine formation (Fig. 5) . In contrast, the addition of human holo-SOD1 enzyme greatly enhanced the formation in all three cases. The SOD activity in the mixture with the human holo-SOD1 protein was 4860 ± 205 units/mg of protein and was decreased by 21% in the BSA mixture after the peroxynitrite treatment.
The SOD1-catalyzed nitrotyrosine formation is residue and protein specific
After BSA was incubated with peroxynitrite alone, three tyrosine residues (Y161, Y357, and Y424) were found to be nitrated. Four additional nitrotyrosine residues, Y108, Y179, Y184, and Y475, were detected in BSA incubated with peroxynitrite with added bovine SOD1 enzyme. A representative MS/MS-based identification of nitrotyrosine in BSA (Supplemental Fig. 1) showed that Y475 was nitrated by peroxynitrite in the presence of bovine SOD1 enzyme, and all the ions in the y ion series starting at y 8 and higher were shifted by 45.0 amu compared to the corresponding native peptide of BSA treated with peroxynitrite alone. This shift confirmed nitration at tyrosine residue. No nitrotyrosine was found in the bovine SOD1 protein on the basis of 60% sequence coverage, including both Y108 and Q131, which were previously suspected to be the nitrated targets [10] . When the liver homogenates of SOD1 −/− mice were incubated with peroxynitrite alone, only 10 proteins were identified from the reaction mixture immunoprecipitated by the nitrotyrosine antibody. In contrast, there were 20 proteins identified from the liver precipitates treated with peroxynitrite and added bovine SOD1 enzyme. The 10 candidate proteins uniquely associated with bovine SOD1 catalysis are listed in Table 2 .
Discussion
The most significant finding from this study is that knockout of SOD1 attenuated or diminished hepatic protein nitration in mice induced by two types/doses of stimuli. Although the two stimuli APAP and LPS display different chemical properties, metabolic fates, target organs, and abilities to induce NO or peroxynitrite formation [48, 49] , the impacts of SOD1 knockout on their induced hepatic protein nitration were similar. The inability of either compound to induce strong hepatic protein nitration in the SOD1 −/− mice as in the WT indicates a general need for SOD1 to catalyze the process in vivo.
Because the catalytic role of SOD1 in protein nitration has been shown in vitro [9, 10, 40, 50] , our results provide direct evidence for such a role for SOD1 in vivo. The diminished hepatic protein nitration in the SOD1 −/− mice was unlikely to be due to a limited NO formation or secondary changes associated with SOD1 knockout. Both treatments of APAP and LPS resulted in similar differences in hepatic protein nitration between the SOD1 −/− and the WT mice, despite a large variation (0 to 79%) of genotype differences in plasma NO concentrations. Although NO is needed for the formation of peroxynitrite, and inhibition of NO synthesis attenuates protein nitration in some instances [28, 51] , protein nitration may take place at baseline NO production and thereby is not strictly dependent on elevated NO concentrations [24, 26, 28] . In fact, expression of inducible nitric oxide synthase in liver was not different between the WT and the SOD1 −/− mice (data not shown). More convincingly, adding the same amount of peroxynitrite in the liver homogenates produced remarkably less nitrotyrosine in the SOD1 −/− mice than in the WT mice. This in vitro genotype difference resembled the in vivo case. Thus, the lack of SOD1 activity, instead of peroxynitrite supply, was the primary or limiting factor responsible for the attenuated hepatic protein nitration in the SOD1 −/− mice. Furthermore, adding bovine SOD1 enzyme into the liver homogenates of both genotypes resulted in activity-dependent increases in the peroxynitrite-induced nitrotyrosine formation. The genotype difference was nearly eliminated at the high level of SOD1 enzyme addition. Only the holo-SOD1 enzyme, not the Cu,Zndepleted apo-SOD1 protein, was able to enhance the peroxynitritemediated nitrotyrosine formation in BSA and liver homogenates. These types of rescues strongly suggest that the lack of SOD1 activity per se, instead of compensatory changes or an accelerated nitrotyrosine degradation [52, 53] caused by the SOD1 knockout, was responsible for the greatly attenuated hepatic protein nitration in the APAP-or LPS-treated SOD1 −/− mice.
The catalytic or promoting role of SOD1 in in vivo hepatic protein nitration demonstrated in this study is in contrast to observations from several previous experiments. Overexpression of SOD1 in mice prevented nitration of tyrosine hydroxylase [54] and APAP toxicity [31] . Those impacts from the elevated SOD1 activity represented pharmacological rather than the actual metabolic roles of SOD1. That protection was likely to decrease the steady-state levels of superoxide and consequently the formation of peroxynitrite. Meanwhile, copperdeficient mouse embryos with low SOD1 activity showed an increased protein nitration [55] , and a 3-week ethanol feeding enhanced liver nitrotyrosine formation in SOD1 −/− mice [56] . In these two cases, the elevated protein nitration was probably caused by secondary metabolic changes [57, 58] resulting from complex changes in the body other than just a SOD1 activity decrease from the copper deficiency and the interaction between long-term ethanol feeding and SOD1
ablation. Because the above-described impacts of SOD1 overexpression and knockout on protein nitration seem to be asymmetric, we compared the responses of SOD1 heterozygous mice (SOD1 +/− ) to the APAP-induced hepatic protein nitration and related toxicity with The backbone of the structure is shown by using a ribbon representation colored red. Nitrated tyrosine residues are shown using a CPK representation. Residues in cyan correspond to those nitrated when BSA was treated with peroxynitrite alone. Residues in green were found in BSA after treatment with peroxynitrite in the presence of added bovine SOD1 enzyme. All other side chains in the structure were omitted except for cysteine residues involved in S-S bonds, which are shown in yellow using a stick representation.
those of the WT and SOD1 −/− mice (Supplemental Figs. 2 and 3 and Supplemental Table 1 ). Our data show that liver protein nitration, mouse survival time, and mouse resistance to hepatotoxicity from APAP were SOD1 activity dose dependent. All responses of the SOD1 +/− mice were between those of the WT and the SOD1 −/− mice.
Our proteomic analysis provides several new leads to understanding the catalytic mechanism of SOD1 in protein nitration. Whereas the inability of the apo-SOD1 protein to enhance the peroxynitrite-mediated nitrotyrosine formation confirms the earlier view that Cu in SOD1 protein is involved in the reaction between peroxynitrite and the enzyme to form an intermediate with the reactivity of nitronium ion that nitrates tyrosine residues of proteins [10, 15] , nitrotyrosine was not detected in the two tryptic peptides of the added bovine SOD1 protein covering two previously suspected target residues, Y108 and Q131 [10] . Thus, other residues in the enzyme might be serving as the intermediate transfer for passing the nitro group to the target proteins. In addition, other types of modifications of the SOD1 protein by the peroxynitrite treatment might contribute to the postreaction decrease in SOD1 activity in the mixture. Based on the modeled crystal structure of BSA (Fig. 6) , locations of the three tyrosine residues nitrated by peroxynitrite alone were as follows: Y161 is buried, Y357 is situated in a small cleft, and Y424 is on the surface. Two (Y108 and Y184) of the four additional tyrosine residues nitrated by peroxynitrite with added bovine SOD1 enzyme are buried inside the structure. Although six of the seven nitrated tyrosine residues by the latter treatment lie in regions with highly positive electrostatic potential values, surrounded by a number of positively charged residues (Supplemental Fig. 4) , a significant structural rearrangement of BSA may be required for the nitration of the buried tyrosine residues. Conceivably, the peroxynitrite treatment could cause BSA to undergo a local conformational change to render certain buried regions available, and SOD1 enzyme might facilitate the process. Based on the genome annotation database DAVID [59] , the 10 unique proteins that were presumably nitrated by peroxynitrite under catalysis by SOD1 enzyme bear the following functional annotation: 4 in mitochondria, 8 in cytoplasm, 3 in endoplasmic reticulum or peroxisomes, 8 related to metabolism, 7 with catalytic activity (4 with transferase activity and 3 with oxidoreductase activity), and 4 dealing with generation of precursor metabolites and energy. More interestingly, at least 4 of the 10 proteins have been previously shown to be related to APAP toxicity [60, 61] . It is our future interest to find out if and how nitration of these proteins in mouse liver affects their resistance to APAP toxicity.
Altogether, our data show that SOD1 activity is important for the catalysis of APAP-and LPS-induced hepatic protein nitration in mice. The catalysis is not directly related to plasma NO concentrations, peroxynitrite availability, or secondary alterations associated with the SOD1 knockout. More than a decade after the demonstration of the role of SOD1 in catalyzing nitrotyrosine formation in vitro [9, 10, 14] , we have provided direct evidence for such a role for SOD1 in vivo. The application of mass spectrometry and proteomic analysis helps elucidate the structural mechanism of that catalytic function of SOD1 and its metabolic implications.
